New study aims to unlock better care for frail lymphoma patients

NCT ID NCT07335120

Recruiting now Knowledge-focused Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting information and samples from 800 people with large B-cell lymphoma who are either too frail for standard treatment or have not responded to initial therapy. The goal is to understand how these patients are managed and what outcomes they have, which could guide future research and improve care. No new treatments are being tested; instead, researchers will analyze real-world data to find patterns.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could guide better treatment approaches for patients who cannot tolerate standard chemotherapy or have relapsed.
What could go wrong: This is an observational study, not testing a new treatment. It may not directly lead to new therapies, and results depend on data quality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DLBCL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma large B-cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DLBCL

Contacts and locations

Locations

The Clatterbridge Cancer Centre NHS Foundation Trust
RECRUITING

Liverpool, Merseyside, L78YA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.